https://pubmed.ncbi.nlm.nih.gov/15899831/
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2...
Inhibition of vascular endothelial growth factor-A (VEGF) signaling is a promising therapeutic approach that aims to stabilize the progression of solid...
highly potent
https://experts.umn.edu/en/publications/phase-i-dose-escalation-and-pharmacokinetic-study-of-azd2171-an-i/fingerprints/
Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular...